Introduction
============

In recent years, the synthesis and biofunctionalization of water-dispersible gold nanoparticles (GNPs) have attracted intense interest due to their potential use in biology and medicine.[@b1-ijn-9-4935]--[@b4-ijn-9-4935] Some of the major biomedical applications of GNPs include gene therapy,[@b5-ijn-9-4935] protein delivery,[@b6-ijn-9-4935] cancer diagnosis,[@b7-ijn-9-4935],[@b8-ijn-9-4935] photothermal and photodynamic therapy,[@b1-ijn-9-4935] and delivery of antitumor agents.[@b1-ijn-9-4935]--[@b4-ijn-9-4935],[@b9-ijn-9-4935]

The most commonly used method for the synthesis of GNPs is the reduction of chloroauric acid by trisodium citrate.[@b10-ijn-9-4935] Other chemical and physical techniques involve the use of powerful and highly toxic reducing agents such as hydrazine and sodium borohydride, as well as high temperature and pressure conditions.[@b11-ijn-9-4935] Moreover, the synthesis of the GNPs can be performed in the presence of a stabilizer in order to modify the surface by physisorption, specific recognition, and electrostatic interactions to ensure stability,[@b12-ijn-9-4935],[@b13-ijn-9-4935] which is an important determinant for the potential use of gold nano-conjugated as therapeutic agents.[@b14-ijn-9-4935] In order to minimize or eliminate further chemical interventions and to improve the sustainability of the process, alternative biosynthetic green methods that utilize plant-based phytochemicals for reduction of metal ions provide an inherently green approach to nanotechnology, also referred to as "green nanotechnology".[@b15-ijn-9-4935]

Recently, several studies have demonstrated the dual role of whole plant extracts and pure compounds isolated from plants as effective reducing agents and as stabilizers, to provide a robust coating on the biocompatible GNPs.[@b16-ijn-9-4935]--[@b20-ijn-9-4935] The reactive phytochemical species include polyphenols such as flavonoids and nonflavonoids, the most abundant antioxidants in human diets, usually found in some fruits, vegetables, and beverages.[@b21-ijn-9-4935],[@b22-ijn-9-4935]

In this study we investigated the capability of three different natural polyphenols, epigallocatechin-3-gallate (EGCG), resveratrol (RSV), and fisetin (FS), to provide synergistic chemical reduction of gold salts to GNPs, as well as stabilization in a single-step green process ([Figure 1](#f1-ijn-9-4935){ref-type="fig"}).

These polyphenols, with different chemical structures, have been selected because they have received a great deal of interest worldwide as potent bioactive substances endowed with chemopreventive/therapeutic activities because of their anti-invasive and antiproliferative effects in a wide variety of tumor cells,[@b23-ijn-9-4935]--[@b26-ijn-9-4935] with an increased effectiveness when formulated into a variety of nanosystems.[@b27-ijn-9-4935]--[@b31-ijn-9-4935]

On the other hand, the functionalization of GNPs' surface with these bioactive substances might provide a new useful approach as delivery and therapeutic tools, in particular by improving the biopharmaceutical properties of these polyphenols, such as their poor bioavailability and stability, as well as their resistance to specific/nonspecific metabolic processes.

As far as the chemical structure is concerned, EGCG (ie, \[-\]-epigallocatechin-3-gallate) is a flavonoid constituted by a dihydroxybenzopyran scaffold carrying a pyrogallol-type structure on the B-ring and a galloyl moiety in the D-ring ([Figure 1](#f1-ijn-9-4935){ref-type="fig"}). RSV (ie, *trans*-3,5,4′-trihydroxystilbene) is a triphenolic phytoalexin having the *trans*-stilbene skeleton, while FS (ie, 3,3′,4′,7-tetrahydroxyflavone) is a flavone-3-ol that bears a catecholic structural unit in the B-ring and the two hydroxyl groups located in the C- and A-rings ([Figure 1](#f1-ijn-9-4935){ref-type="fig"}).

To date, few examples of EGCG-conjugated nanogold have been reported. In a pioneering work, Nune et al[@b32-ijn-9-4935] investigated the role of phytochemicals present in black tea leaves and commercially available catechins to provide GNPs with therapeutic potential. More recently, they demonstrated that biocompatible radioactive GNPs stabilized by EGCG bind with excellent affinity to laminin receptors overexpressed in prostate tumor cells, and reduce prostate tumor volumes in vivo.[@b33-ijn-9-4935] Furthermore, Hsieh et al[@b34-ijn-9-4935] reported on the synthesis, characterization, antioxidant activity, cytotoxicity in vitro, as well as anticancer activity in vivo of EGCG-conjugated nanogold.

The reaction mechanism for the formation of GNPs in aqueous solution by polyphenols reduction has been proposed in several reports.[@b35-ijn-9-4935]--[@b37-ijn-9-4935] Polyphenols such as EGCG demonstrated to be efficient ligands for metal ions and multiple phenolic hydroxyls are able to bind Au^3+^ ions by forming stable chelating rings. As a consequence of complexation, a redox reaction occurs, and the chelated Au^3+^ ions are reduced to Au^0^ atoms in situ, while a part of the phenolic hydroxyls is simultaneously oxidized to corresponding quinone. Thus, polyphenolic molecules result in being physically attached onto the surface of nanogold particles, and the binding of an O atom of the polyphenol molecule to the GNPs' surfaces is presumably due to the electron transfer from O atoms to Au^3+^ ions, as confirmed by computational studies.[@b38-ijn-9-4935] On the other hand, the high density of free hydroxyl groups, especially in EGCG-GNPs, could lead to extensive inter- and intramolecular hydrogen bonding, which favors formation of unique supramolecular assemblies.

However, so far, the potential of RSV and FS as reducing agents for the synthesis of GNPs, as well as on their putative effectiveness when attached on the GNPs' surface, has not been explored yet. Therefore, it could also be interesting to preliminarily explore the behaviour of GNPs decorated with these polyphenols (ie, EGCG, RSV, and FS).

More specifically, we sought to test whether or not the intrinsic antioxidant activity displayed by the free compounds was retained when they are adsorbed to the nanoparticles (NPs) surface. Moreover, we wanted to investigate the ability of these engineered capped GNPs in regulating and modulating cellular responses, by evaluating their antiproliferative activity and induction of apoptosis on stable clones of neuroblastoma SH-SY5Y cells expressing CFP-DEVD-YFP reporter.

Herein, we report on "green nanosynthesis" and characterization, in terms of physicochemical properties and polyphenols content, of novel prototypes of polyphenol-capped GNPs ([Figure 1](#f1-ijn-9-4935){ref-type="fig"}) suitable for biomedical finalization. In vitro stability of the colloidal suspensions in various physiological media was also investigated. Furthermore, the capability of obtained GNPs for scavenging free radicals was demonstrated in vitro by following the reaction with stable 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) cation (ABTS) radicals. Finally, cell viability after treatment with an EGCG-GNP model was evaluated through a 3(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, and activation of the apoptotic pathways was investigated by Western blot analysis.

Materials and methods
=====================

Chemicals and reagents
----------------------

Tetrachloroauric acid (III) trihydrate (HAuCl~4~•3H~2~O, \>99.5% purity), DPPH, ABTS, and GNPs (15 nm diameter, stabilized suspension in citrate buffer) were purchased from Sigma--Aldrich (Steinheim, Germany). EGCG (≥99% purity) and RSV (≥98% purity) were purchased from Zhe-jiang Yixin Pharmaceutical Co., Ltd. (Zhejiang, People's Republic of China). FS (.98% purity) was purchased from Shaanxi Taiji Huaqing Technology Co., Ltd. (Shaanxi, People's Republic of China).

Synthesis of GNPs
-----------------

The synthesis of GNPs was carried out by modification of a method previously reported.[@b32-ijn-9-4935] Aqueous solution of HAuCl~4~•3H~2~O (10 mM, 1.0 mL) and polyphenol (EGCG, RSV, or FS) solution (1.0 mM, 5.0 mL) was mixed under gentle stirring at room temperature. EGCG was solubilized in water, while RSV and FS were solubilized in ethanol:water mixture (1:4, v/v). The color of the mixture containing EGCG and RSV turned purple--red from pale yellow within a few minutes, indicating the formation of GNPs. For the solution containing FS the color appeared orange then yellow and purple--red after about 10 minutes. The reaction mixture was stirred for an additional 30 minutes. The GNPs were collected by centrifugation (20,000 rpm, 10 minutes, 15°C) and washed three times with water to ensure that no unbound EGCG, RSV, or FS molecules remained in the NP dispersion.

Characterization
----------------

The ultraviolet-visible (UV-vis) absorbance spectrum of diluted aqueous NP suspensions was recorded using a Cary 3 UV-vis spectrophotometer (Varian Medical Systems, Inc., Palo Alto, CA, USA).

The morphology and size of the GNPs were characterized by transmission electron microscopy (TEM) (FEI Tecnai G12; FEI, Hillsboro, OR, USA). A drop of sample was placed on a formvar-coated 400 mesh copper grid, followed by drying the sample at ambient conditions before it was attached to the sample holder on the microscope.

The phase characteristics of the as-prepared products were examined by powder X-ray diffraction (XRD; Bruker D8 Advance diffractometer) using Cu Kα radiation (λ=1.54056 Å), operating at 40 kV and 40 mA. Results were recorded in the 2θ range from 20° to 80° with a scanning step of 0.02° per step and 2 seconds per point.

Infrared spectra were collected on a Fourier transform infrared (FT-IR) spectrometer (Bruker Optics, Ettlingen, Germany) at a resolution of 4 cm^−1^ in KBr pellets. The measurements were performed on EGCG, RSV, and FS raw materials as well as on GNPs produced.

Determination of polyphenol content
-----------------------------------

The polyphenol content was determined by spectrophotometry, using EGCG, RSV, and FS as standard, with some modifications of the method described.[@b39-ijn-9-4935],[@b40-ijn-9-4935] Briefly, 0.1 mg of the GNPs was transferred to separate tubes containing 0.5 mL of a 1/10 dilution of Folin--Ciocalteu's reagent in water. Then, 1.0 mL of a sodium carbonate solution (7.5% w/v) was added. The tubes were then allowed to stand at 30°C for 30 minutes before absorbance at 760 nm was measured. The polyphenol content was expressed as EGCG, RSV, and FS equivalents in μg/100 μg GNPs. The concentration of polyphenol in samples was derived from the standard curve of EGCG, RSV, and FS raw materials ranging from 0.1 to 10 μg/mL (EGCG: y=0.0563x+0.0101; *R*^2^=0.9993; RSV: y=0.0765x+0.0086; *R*^2^=0.9990; FS: y=0.0649x+0.0104; *R*^2^=0.9991) ([Figure S1](#SD1-ijn-9-4935){ref-type="supplementary-material"}).

In vitro stability
------------------

In vitro stability studies of GNPs were performed in different media as previously reported.[@b32-ijn-9-4935] Typically, colloidal NP solution was added to glass vials containing 1.5 mL of 0.5% bovine serum albumin (BSA), 0.5% cysteine, 5.0% sodium chloride (NaCl), and phosphate-buffered solution (PBS) pH 5, pH 7, and pH 9, respectively, and incubated for 3 hours at room temperature. The stability of GNPs was measured by monitoring UV absorbance at 30-minute intervals. A negligible change in UV-vis plasmon band confirmed the retention of nanoparticulate composition in all mixtures.

Antioxidant test: DPPH assay
----------------------------

The capacity of plant materials to catalyze the decomposition of free radicals can be determined by their ability to reduce the concentration of the stable free radical DPPH.[@b41-ijn-9-4935] The method previously described by Gülçin[@b42-ijn-9-4935] was used with slight modifications. Stock solutions of DPPH were prepared at 0.1 mmol/L in ethanol and stored at -20°C until needed. An appropriate amount of GNPs dispersed in ethanol (500 μL) was added to 1.0 mL DPPH solution in a test tube to give different final concentrations of NPs (25, 50, 100, and 200 μg/mL). The mixture was sonicated for 5 minutes and then left to stand in the dark. The supernatant containing only DPPH was obtained by centrifuging at 20,000 rpm for 5 minutes. Nonfunctionalized GNPs commercially available were tested as comparison at the same concentration.

The absorption of the supernatant was measured at 517 nm against blank samples lacking scavenger using a UV-vis spectrophotometer. The decrease in absorbance was determined at 5-minute intervals up to 30 minutes. The scavenging percentage was calculated using the following formula: $$\text{DPPH-scavenging~effect}\ (\%) = \left\lbrack \frac{(\text{ABS}_{\text{Control}} - \text{ABS}_{\text{Sample}})}{\text{ABS}_{\text{Control}}} \right\rbrack \times 100$$

where ABS~Control~ and ABS~Sample~ are absorption of control DPPH and sample applied DPPH at 517 nm, respectively.

Antioxidant test: ABTS assay
----------------------------

The ABTS radical cation decolorization test is a spectrophotometric method widely used for the assessment of antioxidant activity of various substances. The experiment was carried out by adapting a method previously reported.[@b43-ijn-9-4935] In brief, a mixture containing 99 mL of ABTS solution (5.0×10^−4^ M) and 1.0 mL of sodium persulfate (6.89×10^−3^ M) was stored in the dark at room temperature for 16 hours before use. The produced ABTS•+ solution was diluted with ethanol to obtain an absorbance of approximately 0.85 at 734 nm. After the addition of 900 μL of diluted ABTS• solution to 100 μL of sample, the absorbance reading was taken at 1-minute intervals up to 5 minutes. Nonfunctionalized GNPs commercially available were used as comparison. A sample blank was run in each assay. All determinations were carried out in triplicate after centrifugation at 20,000 rpm for 1 minute. The percentage radical-scavenging activity was calculated as follows: $$\text{ABTS} \bullet + \text{-scavenging~effect}\ (\%) = \left\lbrack \frac{(\text{ABS}_{\text{Control}} - \text{ABS}_{\text{Sample}})}{\text{ABS}_{\text{Control}}} \right\rbrack \times 100$$

where ABSControl is absorbance of a control lacking any radical scavenger and ABSSample is absorbance of the remaining ABTS•+ in the presence of a scavenger.[@b44-ijn-9-4935]

Cell culture
------------

Human neuroblastoma SH-SY5Y cells (American Type Culture Collection number CRL-2266) were cultured in Dulbecco's Modified Eagle Medium F-12 (DMEM/F12) ground (Life Technologies, Carlsbad, CA, USA) in the presence of 10% fetal calf serum (Life Technologies) inactivated at 56°C for 30 minutes. The cells are grown in an incubator at 37°C in a humidified atmosphere containing 5% CO~2~. Stable clones expressing CFP-DEVD-YFP (Addgene company code 24537) were obtained by transfecting cells with LipofectAMINE LTX and PLUS reagent (Life Technologies) using 1.5 μg DNA/5--7×10^5^ cells according to the manufacturer's protocol. The different SH-SY5Y clones were maintained under selection by 400 μg/mL of G418. Individual clones expressing antibiotic resistance were picked after 14 days of selection, moved into a 48-well plate, and maintained in selective medium until confluence growth. Different individual clones were analyzed for CFP-DEVD-YFP expression upon treatment with the caspase-3 activator staurosporine (1 μg/mL).

Assessment of cell viability
----------------------------

The viability of control SH-SY5Y-CFP-DEVD-YFP cells was calculated after 72 hours through an MTS assay. Cell viability was assessed by a colorimetric assay using the MTS assay (CellTiter 96 Aqueous One Solution Assay; Promega Corporation, Madison, WI, USA), according to the manufacturer's instructions. Absorbance at 490 nm was measured in a multilabel counter (Victor X5; Perkin Elmer, Waltham, MA, USA).

Immunofluorescence
------------------

One×10^5^ cells were grown on a cover-glass for 24 hours and treated with staurosporine (1.0 μM) for 2 hours. Cells were washed twice with PBS 1X and then fixed with 1 mL of 4% paraformaldehyde/PBS 1X for 10 minutes. Before analysis, cells were mounted using Mowiol mounting medium[@b45-ijn-9-4935] and fluorescence was revealed with a Leica TCS SP5 confocal microscope with LAS lite 170 image software.

Western blot analysis
---------------------

Western blot analysis was performed as previously described.[@b46-ijn-9-4935] Briefly, protein content was determined using the Bradford protein assay. Equal amounts of protein extracts were resolved by standard sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Samples were electroblotted onto Protan nitrocellulose (Schleicher and Schuell BioScience GmbH, Dassel, Germany). Membranes were incubated with 3% low-fat milk in 1X PBS-Tween 0.05% solution with rabbit anti-green fluorescent protein (anti-GFP; Enzo Life Science, Farmingdale, NY, USA; 1:1,000 final dilution) or mouse anti-β-actin (Sigma-Aldrich; 1:1,000 final dilution) for 16 hours at 4°C. Goat antimouse immunoglobulin G (IgG) peroxidase-conjugated antibody (Millipore Corporation, Billerica, MA, USA; 1:2,500 final dilution) or goat antirabbit IgG peroxidase-conjugated antibody (Millipore; 1:2,500 final dilution) were used to reveal immunocomplexes by enhanced chemiluminescence (Pierce Biotechnology, Rockford, IL, USA).

Statistical analysis
--------------------

Data are expressed as the mean ± standard deviation of experiments carried out in triplicate. The significance of differences was assessed by one-way analysis of variance. Individual differences were evaluated using a nonparametric post hoc test (Tukey's test) and considered statistically significant at *P*\<0.05.

Results and discussion
======================

Synthesis and characterization of GNPs
--------------------------------------

In this study, green reduction of Au^3+^ to GNPs by bioactive polyphenols EGCG, RSV, and FS was performed by simply mixing polyphenol and metal gold salt solutions at room temperature. The reaction was complete within minutes and the formation of EGCG-, RSV-, and FS-capped GNPs could be followed by color change from yellow to reddish violet ([Figure S1](#SD1-ijn-9-4935){ref-type="supplementary-material"}), due to excitation of surface plasmon resonance (SPR) vibration of GNPs.

In UV-vis absorbance spectra ([Figure 2](#f2-ijn-9-4935){ref-type="fig"}), synthesis of GNPs was confirmed by characteristic SPR peak centered at 554, 540, and 544 nm for EGCG-, RSV-, and FS-capped GNPs, respectively. The significant SPR shift to higher wavelengths observed for EGCG-GNPs suggests an increase in particle size compared with NP batches prepared using RSV and FS.[@b47-ijn-9-4935]

The size and shape of the GNPs were investigated with TEM. The images reported in [Figure 3](#f3-ijn-9-4935){ref-type="fig"} show that EGCG-GNPs ([Figure 3A](#f3-ijn-9-4935){ref-type="fig"}) are in variable shapes. Most of them are spherical in nature, followed by occasionally triangular and rarely hexagonal.

On the other hand, a more uniform size distribution and homogeneous spherical shape of RSV and FS-GNPs were observed ([Figure 3B and C](#f3-ijn-9-4935){ref-type="fig"}, respectively). As reported in [Table 1](#t1-ijn-9-4935){ref-type="table"}, the size of the NPs was in the range of 10--25 nm and was influenced by the polyphenol used in the synthetic procedure.

These findings suggest that EGCG, RSV, and FS could be successfully used as reducing and stabilizing agents to produce GNPs with a narrow size distribution. Significant differences (*P*\<0.05) were found in mean diameter of EGCG-GNPs with respect to FS-GNPs.

The powder XRD patterns ([Figure 4](#f4-ijn-9-4935){ref-type="fig"}) showed that synthesized GNPs were crystalline. The pattern presents four distinct diffraction peaks at 38.17, 44.33, 64.70, and 77.70, which are assigned to (1 1 1), (2 0 0), (2 2 0), and (3 1 1) crystalline plane diffraction peaks of cubic GNPs, respectively, in agreement with the database of the Joint Committee on Powder Diffraction Standards (JCPDS No 04-0784). The absence of any other crystallographic impurities peaks in the XRD spectrum confirmed the high purity of synthesized GNPs, in accordance with that reported earlier for similar prototypes.[@b48-ijn-9-4935]

The average particle size was estimated using the Scherrer equation: $$d = (k\lambda/\beta 1/2\ \text{cos}\ \theta)$$

where k is the Scherrer constant (0.89), λ is the X-ray wavelength of Cu Kα1 radiation, β1/2 is the width of the XRD peak at half-height, and θ is the Bragg angle.

The average size of the NPs, calculated from the width of the diffraction peak, was about 19.49, 12.16, and 9.90 nm for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively, which were in line with the results obtained from TEM measurements.

To acquire further information about the presence of polyphenols coating in the NP surface, FT-IR measurements of both free polyphenols and the corresponding gold-capped derivatives were assessed.

The analysis of FT-IR spectrum of free compounds and corresponding capped GNPs evidenced an overlapping behavior between all three couples of samples ([Figure 5](#f5-ijn-9-4935){ref-type="fig"}). In particular, the spectra of EGCG and EGCG-GNPs are characterized by the typical C=O ester band at about 1,700 cm^−1^ ([Figure 5A](#f5-ijn-9-4935){ref-type="fig"}). Moreover, aromatic double-bond stretching at about 1,610 cm^−1^, aromatic C--C stretching at 1,450 cm^−1^, O--H bending vibration centered at 1,375 cm^−1^, and C--O stretching at 1,210 cm^−1^ were also detected in both samples. Spectra of RSV and RSV-GNPs ([Figure 5B](#f5-ijn-9-4935){ref-type="fig"}) revealed four intense bands at about 1,610, 1,590, 1,450, and 1,150 cm^−1^, corresponding to C--C aromatic double-bond stretching, C--C olefinic stretching, aromatic C--H stretching, and C--C aromatic bending vibration, respectively. Finally, FS and its nanogold derivative showed similar pattern signals ([Figure 5C](#f5-ijn-9-4935){ref-type="fig"}), which are constituted by C=O stretching of the ketone functionality located on the chromen-4-one ring (1,725--1,690 cm^−1^), C=C stretching (1,605 cm^−1^), C--C stretching (1,260 cm^−1^), and C--OH bending vibration (1,110 cm^−1^).

Determination of polyphenol content
-----------------------------------

Since GNPs can be proposed as suitable carriers for the delivery of bioactive EGCG, RSV, and FS, as well as for other related phytochemicals, it is important to determine the amount of polyphenols adsorbed on the NPs' surface.

To evaluate the EGCG, RSV, and FS content in gold nanosystems, the rapid colorimetric Folin--Ciocalteu method, frequently used for quantification of total phenolic content in natural products, was considered in this study.[@b49-ijn-9-4935] We derived the concentration of each polyphenol in NPs from the standard curve prepared using EGCG, RSV, and FS raw materials ([Figure S2](#SD2-ijn-9-4935){ref-type="supplementary-material"}). The percentage of polyphenol content resulted as 2.71%, 3.23%, and 5.47% (w/w) for GNPs synthesized using EGCG, RSV, and FS, respectively.

In vitro stability
------------------

One of the most important aspects to be taken into account for various biomedical applications of GNPs is their stability in physiological media, in order to prevent aggregation.[@b32-ijn-9-4935] In fact, it represents a key issue that underlies multiple deleterious effects in many therapeutics, including loss of efficacy, altered pharmacokinetics, and induction of unwanted immunogenicity.

The stability of polyphenol-capped GNPs was monitored using absorption spectroscopy in 0.5% BSA, 0.5% cysteine, and 5.0% NaCl solutions over 3 hours. We have also investigated the stability of GNPs in PBS at pH 5, 7, and 9.

On the whole, the plasmon wavelengths in all the tested GNPs ([Figure 6A--C](#f6-ijn-9-4935){ref-type="fig"}) show minimal shifts of 1--5 nm, confirming that the NPs are intact, thus demonstrating good in vitro stability in simulated biological fluids. These results confirm that EGCG, RSV, and FS are acting in stabilizing gold nanoparticulate systems from agglomerations in solution. It was also observed that at pH 9 all GNPs are characterized by a more remarkable (7--12 nm) blue shift in SPR band. As previously reported, the shift in SPR can be correlated with NPs' surface charge at different pH.[@b50-ijn-9-4935] In alkaline pH, the presence of a high concentration of hydroxyl ions on the surface of NPs might maximize their repulsive electrostatic and electrosteric interactions, thus reducing particles aggregation, as detected by the hypsochromic shift of UV-vis peak.[@b48-ijn-9-4935]

On the other hand, when colloidal gold solution was added into BSA, the position of the peak of colloidal gold slightly shifted red (\~7 nm). These results could be attributed to the possible formations of BSA--colloidal gold complex, probably due to the interaction with free thiol groups of protein.[@b51-ijn-9-4935]

Concerning RSV-GNPs and FS-GNPs, a slight red shift (7 and 10 nm, respectively) was also observed when the strong electrolyte (ie, NaCl) was added at 5.0% concentration; the high concentration of ions presumably shielded the repulsive electrostatic forces between NPs, allowing them to form small aggregates. Considering that in physiological conditions the concentration of NaCl corresponds to 0.9% (150 mM), all produced GNPs can be considered stable.

Antioxidant activity: DPPH assay
--------------------------------

Measurement of radical-scavenging activity using discoloration of DPPH has been widely used due to its stability, simplicity, and reproducibility.[@b42-ijn-9-4935]

As shown in [Figure 7A](#f7-ijn-9-4935){ref-type="fig"}, all GNPs scavenged DPPH radicals in a dose-dependent manner and shared a good linear correlation between the percentage inhibition of the DPPH and the amount of GNPs used (ECGG-GNPs: *R*^2^=0.9534; RSV-GNPs: *R*^2^=0.9295; FS-GNPs: *R*^2^=0.9880).

At all tested concentrations, EGCG-GNPs and FS-GNPs exhibited a similar DPPH-scavenging activity. Percentage inhibition of DPPH ranged from about 16% and 19% at a lower concentration (25 μg/mL) to 60% and 66% obtained at higher concentration (200 μg/mL) for EGCG-GNPs and FS-GNPs, respectively. On the contrary, the RSV-GNPs showed a significantly lower (*P*\<0.05) free radical-scavenging effect when compared with EGCG-GNPs and FS-GNPs, with only 26% of scavenging activity at 200 μg/mL.

Moreover, the kinetics of DPPH• radicals-scavenging activity of all GNPs increased with an increase in the concentration, and the decrease in absorbance reached a plateau within the 5-minute sampling period, which indicated that the reaction had reached completion (data not shown).

Antioxidant activity: ABTS assay
--------------------------------

The ABTS assay is another commonly used method available to evaluate antioxidant activities of natural compounds based on their ability to scavenge the long-life radical cation ABTS•+.[@b52-ijn-9-4935]

The results reported in [Figure 7B](#f7-ijn-9-4935){ref-type="fig"} show that radical-scavenging activities of all the GNPs increased linearly with increasing concentration, exhibiting their dose-dependent nature (EGCG-GNPs: *R*^2^=0.9921; RSV-GNPs: *R*^2^=0.9924; FS-GNPs: *R*^2^=0.9993). The antioxidant activity was found to be stronger for FS-GNPs, followed by the RSV-GNPs and then EGCG-GNPs.

The scavenging percentages range from 6%, 8%, and 15% at 25 μg/mL to 46%, 51%, and 55% at higher concentration (200 μg/mL) for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively. Interestingly, at all tested concentrations, the reaction reaches steady state conditions after the first 2 minutes (data not shown), suggesting that polyphenols on the surface of GNPs maintained a high antioxidant efficiency.

To elucidate in more detail the antioxidant activity differences detected for the obtained GNPs, the DPPH- and ABTS-scavenging effects of EGCG, RSV, and FS raw materials at different concentrations were also evaluated.

As shown in [Figure S3](#SD3-ijn-9-4935){ref-type="supplementary-material"}, the percentage of inhibition for DPPH of all polyphenols showed a good linearity at the tested concentrations. EGCG exhibited the highest antioxidant capacity with a percentage of DPPH inhibition that ranged from 9.5% (0.25 μg/mL) to 66% (2.5 μg/mL). At the same concentrations, values found for FS were decreased and ranged from 8.5% to 60%. On the other hand, RSV showed the lowest antioxidant potential with comparable activity at higher concentrations (62.1% inhibition of DPPH at 20 μg/mL).

These findings are in agreement with previous reports and suggest that the DPPH antioxidant activity of polyphenolic compounds is closely associated with their chemical structure, such as the number and position of phenolic hydrogen, which influences the accessibility to the radical centre of DPPH•. Thus, the greater number of hydroxyl groups, especially *O*-dihydroxy group on B-ring of EGCG and FS with respect to RSV, are potentially able to quench more efficiently the free radicals by forming resonance-stabilized phenoxyl radicals.[@b52-ijn-9-4935]

As concerns ABTS-scavenging activity ([Figure S4](#SD4-ijn-9-4935){ref-type="supplementary-material"}), no significant differences were found for EGCG and RSV, with the percentage of inhibition of about 20% at lower concentration (0.5 μg/mL) and 65% at higher concentration (10 μg/mL). In contrast, the ABTS antioxidant activity of FS, at the same concentrations, decreased significantly, ranging from 16% to 53%.

The different behavior of polyphenols, and in particular of RSV, observed in DPPH and ABTS assays suggests that the reaction mechanisms involved in both methods are influenced by the chemical structure of the antioxidants, and that the two assay cations react by using different active chemical groups. In particular, in contrast to the oxidation of polyphenols by DPPH radicals that occur at B-ring, forming the corresponding O-quinone, or even at the C-2 position of the C-ring, the oxidation of polyphenols by ABTS radical cations occurs at the A-ring.[@b53-ijn-9-4935]

Additionally, no significant DPPH and ABTS antioxidant activities were detected by using as control the nonfunctionalized GNPs at the same concentration of polyphenols-capped GNPs, thus confirming that radical-scavenging activities are due to the presence of polyphenols on the GNPs' surface (data not shown).

Correlations between polyphenol content and antioxidant activity
----------------------------------------------------------------

The correlation coefficients (*R*^2^) were used to evaluate the correlation between each polyphenol content in GNPs and the methods used to determine their antioxidant capacity. As reported in [Figure S5](#SD5-ijn-9-4935){ref-type="supplementary-material"}, the *R*^2^ values between DPPH and polyphenolic content were 0.9654, 0.9578, and 0.9944 for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively. High correlation was also demonstrated between ABTS and poly-phenolic content (*R*^2^=0.9944, 0.9923, and 0.9961 for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively).

These results suggest that the higher DPPH and ABTS antioxidant activities are correlated to the high EGCG, RSV, and FS content in GNPs. The *R*^2^ values for correlations between DPPH and ABTS assays were *R*^2^=0.9335, 0.9374, and 0.9843 for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively ([Figure S6](#SD6-ijn-9-4935){ref-type="supplementary-material"}).

Antiproliferative activity and apoptosis activation in SH-SY5Y-CFP-DEVD-YFP cells
---------------------------------------------------------------------------------

Several polyphenols have shown remarkable cancer-preventive and some cancer-therapeutic effects, partially due to their ability to induce apoptosis in cancer cells without affecting normal cells.

In this scenario, growth-suppressive effect on cell proliferation demonstrated by polyphenols such as EGCG is mediated through programmed cell death or apoptosis by interfering with many cellular processes, including nuclear condensation, caspase-3 activation, and poly-ADP ribose polymerase cleavage, as well as eliciting the production of intracellular reactive oxygen species.[@b54-ijn-9-4935] The essential role of caspases (in particular, the key caspase-3 protein) in EGCG-mediated inhibition of NF-kB and its subsequent apoptosis has also been demonstrated.[@b55-ijn-9-4935]

To assess whether the engineered GNPs may alter cell proliferation and induce apoptosis, we took advantage of the neuronal SH-SY5Y cells stably expressing CFP-DEVD-YFP reporter.[@b56-ijn-9-4935] In this reporter the sequence coding for CFP (CFP: GFP with mutations Y66W, F64L, S65T, N146I, M153T, and V163A) is fused to the one coding for YPF (YFP: a particular GFP variant called Venus with mutations F64L, M153T, V163A, and S175G) via the aminoacidic sequence DEVD, which is the substrate for active caspase-3. Different stable cell lines were generated and characterized for the first time. [Figure 8](#f8-ijn-9-4935){ref-type="fig"} shows the SH-SY5Y stable cell line used in the following experiments. The expression levels of CFP-DEVD-YFP were evaluated by Western blot ([Figure 8A](#f8-ijn-9-4935){ref-type="fig"}) and immunofluorescence ([Figure 8B](#f8-ijn-9-4935){ref-type="fig"}) experiments after induction of apoptosis by staurosporine treatment. As shown in [Figure 8A](#f8-ijn-9-4935){ref-type="fig"}, treatment with staurosporine determined the cleavage of DEVD target sequence and the resulting separation of two fluorescent proteins, indicating the activation of caspase-3.

Next, SH-SY5Y-CFP-DEVD-YFP cells were treated for 72 hours with EGCG-GNPs at different concentrations and cell viability was measured by MTS assay ([Figure 8C](#f8-ijn-9-4935){ref-type="fig"}). At the end of 72 hours of exposure, EGCG-GNPs decreased cell viability approximately in a dose-dependent manner, displaying an overlapping behavior with that of free EGCG. More specifically, both EGGC-GNPs and free EGCG exhibited similar cytotoxicity profiles, showing a dose-dependent antiproliferative effect and inhibition values in the overall cell growth. With respect to control, at 1 μg/mL concentration, EGCG-GNPs determined a growth inhibition of SH-SY5Y-CFP-DEVD-YFP cells of \~10%, similarly to an equivalent amount of free EGCG (ie, cells resulted in being exposed to equimolar amounts of free and capped EGCG). At 5 μg/mL, 10 μg/mL, and 25 μg/mL concentration exposure, tested EGCG-GNPs showed a reduction of cell viability of about 20%--30%, and, finally, treatment of SH-SY5Y-CFP-DEVD-YFP cells with 50 μg/mL of EGCG-GNPs proved the highest cytotoxicity, showing a cell growth inhibition of \~40% ([Figure 8C](#f8-ijn-9-4935){ref-type="fig"}).

Moreover, treatment of cells with EGCG-GNPs (and free ECGG) shared increased CFP-DEVD-YFP reporter cleavage ([Figure 8D](#f8-ijn-9-4935){ref-type="fig"}) due to caspase-3 activation, thus supporting an apoptotic mechanism of action.

In summary, EGCG-GNPs induce a dose-dependent reduction on cell viability that is likely to involve the activation of the apoptotic pathways.

Of course, to evaluate whether these activities may have an in vivo relevance when providing a reasonable dose of these NPs, further studies are in progress to explore a large panel of more responsive tumor cells. However, for comparative purposes, in a previous in vivo study on polymeric NP-mediated delivery of bioactive catechins administered at concentrations ranging 5--20 μg/mouse, the polyphenols loading of NPs resulted in 3.38% and 5.76% of the polymer weight, similar to the concentration of polyphenols found in our prototypes.[@b57-ijn-9-4935]

Conclusion
==========

In this work, green synthesis of GNPs using natural polyphenols EGCG, RSV, and FS was successfully investigated and proposed as a simple, reproducible, low-cost, and nontoxic method. Stable nanogolds were uniformly generated and fully characterized for their physicochemical properties. Overall, enhanced antioxidant properties were detected for all three prototypes, and this correlates well with the high EGCG, RSV, and FS content in GNPs. However, some differences in free radical-scavenging action between the three nano-systems have been observed, due to their peculiar chemical structure. Moreover, a high degree of correlation among the antioxidant activities measured by DPPH and ABTS assays has been found in these polyphenol-capped GNPs. Our data on the antiproliferative activity of EGCG-GNPs in a neuroblastoma cell model demonstrated that these constructs induce a concentration-dependent reduction on cell viability by involving the activation of the apoptotic pathways. Moreover, the effectiveness of EGCG in terms of antiproliferative efficacy can be retained in EGCG-capped GNPs and supports the antioxidant capacity of these polyphenols and their ability to catalyze the decomposition/scavenging of free radicals.

These results would make these stable polyphenol-capped gold nanoprototypes suitable as functional and promising candidates for the treatment of disorders associated with oxida-tive stress, and extensive preclinical studies are warranted.

Supplementary materials
=======================

Figures [S1](#SD1-ijn-9-4935){ref-type="supplementary-material"}--[S6](#SD6-ijn-9-4935){ref-type="supplementary-material"} report details on photographs of colloidal EGCG-GNPs, calibration curves, and antioxidant activity of pure EGCG, RSV, and FS at various concentrations assessed by percentage inhibition of DPPH and ABTS, as well as correlation between radical-scavenging capacity assays (DPPH and ABTS) and correlation between DPPH and ABTS assays of nanogolds.

###### 

Photograph of HAuCl~4~ solution (yellow solution) and colloidal EGCG-GNPs (left), RSV-GNPs (middle), and FS-GNPs (right).

**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.

###### 

Calibration curves of pure (**A**) EGCG, (**B**) RSV, and (**C**) FS used for the determination of polyphenol content.

**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin.

###### 

Antioxidant activity of (**A**) EGCG, (**B**) RSV, and (**C**) FS raw materials at various concentrations assessed by percentage inhibition of DPPH.

**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; DPPH, 2,2-diphenyl-1-picrylhydrazyl.

###### 

Antioxidant activity of (**A**) EGCG, (**B**) RSV, and (**C**) FS raw materials at various concentrations assessed by percentage inhibition of ABTS.

**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; ABTS, 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) cation.

###### 

Correlation between radical-scavenging capacity assays (DPPH and ABTS) of EGCG-GNPs, RSV-GNPs, and FS-GNPs and (**A**) EGCG, (**B**) RSV, and (**C**) FS content (%, w/w).

**Abbreviations:** DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) cation; EGCG, epigallocatechin-3-gallate; GNPs, gold nanoparticles; RSV, resveratrol; FS, fisetin.

###### 

Correlation between DPPH and ABTS assays of (**A**) EGCG-GNPs, (**B**) RSV-GNPs, and (**C**) FS-GNPs.

**Abbreviations:** DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) cation; EGCG, epigallocatechin-3-gallate; GNPs, gold nanoparticles; RSV, resveratrol; FS, fisetin.
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![The work plan: from polyphenols to nanogolds. Chemical structures of EGCG, RSV, and FS are included.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.](ijn-9-4935Fig1){#f1-ijn-9-4935}

![Ultraviolet-visible spectra of stable GNPs synthesized by EGCG, RSV, and FS polyphenols.\
**Notes:** Wavelength expressed in nm. EGCG-GNPs, RSV-GNPs, and FS-GNPs indicate polyphenol-capped nanogold.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.](ijn-9-4935Fig2){#f2-ijn-9-4935}

![Transmission electron microscopy micrographs of (**A**) EGCG-, (**B**) RSV-, and (**C**) FS-capped GNPs.\
**Note:** Distances expressed in nanometers (nm).\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.](ijn-9-4935Fig3){#f3-ijn-9-4935}

![X-ray diffraction pattern of (**A**) EGCG-, (**B**) RSV-, and (**C**) FS-capped GNPs.\
**Note:** Diffraction angle 2θ expressed in degrees.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.](ijn-9-4935Fig4){#f4-ijn-9-4935}

![Fourier transform infrared spectra of (**A**) EGCG-GNPs, (**B**) RSV-GNPs, and (**C**) FS-GNPs, compared with pure EGCG, RSV, and FS, respectively.\
**Note:** Wavenumber expressed in cm^−1^.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.](ijn-9-4935Fig5){#f5-ijn-9-4935}

![In vitro stability ultraviolet-visible studies of GNPs capped with (**A**) EGCG, (**B**) RSV, and (**C**) FS in different media.\
**Notes:** Wavelength expressed in nm. EGCG-GNPs, RSV-GNPs, and FS-GNPs indicate polyphenol-capped nanogold.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; BSA, bovine serum albumin; Cys, cysteine; NaCl, sodium chloride.](ijn-9-4935Fig6){#f6-ijn-9-4935}

![Antioxidant activities of EGCG-GNPs, RSV-GNPs, and FS-GNPs at various concentrations assessed by percentage inhibition of DPPH (**A**) and ABTS (**B**) radicals.\
**Notes:** GNP concentration expressed in μg/mL. EGCG-GNPs, RSV-GNPs, and FS-GNPs indicate polyphenol-capped nanogold.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid).](ijn-9-4935Fig7){#f7-ijn-9-4935}

![Effect of EGCG-GNPs on CFP-DEVD-YFP reporter gene. (**A**) SH-SY5Y-derived cells expressing CFP-DEVD-YFP reporter gene were left untreated (−) or treated (+) for 2 hours with 1 μM staurosporine to induce caspase-3 activation. Cell lysates were subjected to reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The anti-GFP antibody was used to visualize CFP-DEVD-YFP reporter and anti-β-actin serves as control for equal loading of samples. (**B**) Autofluorescence analysis of cells as in (**A**). (**C**) Effect EGCG-GNPs at 1, 5, 10, 25, and 50 μg/mL on SH-SY5Y-CFP-DEVD-YFP cells. (**D**) Western blots on protein extracts from cells treated as in (**C**) were performed using anti-GFP antibody and anti-β-actin as controls for equal EGCG loading of samples (EGCG-GNPs concentration =10 and 50 μg/mL).\
**Notes:** Results for MTS assays are the means ± SEM of three experiments performed in triplicate. Concentration of free EGCG and EGCG capped in GNPs is the same.\
**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; GFP, green fluorescent protein; MTS, 3(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; SEM, standard error of the mean.](ijn-9-4935Fig8){#f8-ijn-9-4935}

###### 

Mean diameter of EGCG-, RSV-, and FS-capped GNPs

  Polyphenol-capped GNPs   Mean diameter ± standard deviation (nm)
  ------------------------ -------------------------------------------------------
  EGCG-GNPs                25.55±7.26[\*](#tfn2-ijn-9-4935){ref-type="table-fn"}
  RSV-GNPs                 14.55±2.20
  FS-GNPs                  9.76±1.56[\*](#tfn2-ijn-9-4935){ref-type="table-fn"}

**Notes:** Diameter expressed in nanometers (nm).

Significantly different from other GNP-polyphenols. EGCG-GNPs, RSV-GNPs, and FS-GNPs indicate polyphenol-capped nanogold.

**Abbreviations:** EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.
